tcsc0456 CDK9-IN-1

CDK9-IN-1 is a novel, selective CDK9 inhibitor for the treatment of HIV infection, with an IC₅₀ of 39 nM for CDK9/CycT1, extracted from reference, compound 87.

IC50 & Target: IC50: 39 nM (CDK9/

CycT1)^[1]

In Vitro: CDK9-IN-1 is a potent CDK9 inhibitor that shows high activity against HIV-1 replication^[1].